The Impact of Structure on the Value of CMO Bonds

A Chasen - The Journal of Structured Finance, 2009 - jsf.pm-research.com
Despite the recent negative attention, mortgage securitization provides a vehicle to take
assets without much investor appeal and create bonds whose risk and return profiles are …

Data Commoditization in the Securitization Markets

J Broad, A Chasen - The Journal of Structured Finance, 2011 - pm-research.com
Data is the lifeblood of the securitization industry, and the lack of ready access to it and
proper tools to analyze it was considered to be a primary flaw in the recent credit crisis. This …

[HTML][HTML] Phase 3 Trial of 177Lu-Dotatate for Midgut Neuroendocrine Tumors

…, E Wolin, A Hendifar, J Yao, B Chasen… - … England Journal of …, 2017 - Mass Medical Soc
Background Patients with advanced midgut neuroendocrine tumors who have had disease
progression during first-line somatostatin analogue therapy have limited therapeutic options. …

The vacuolar zinc transporter TgZnT protects Toxoplasma gondii from zinc toxicity

NM Chasen, AJ Stasic, B Asady, I Coppens… - Msphere, 2019 - Am Soc Microbiol
Zinc (Zn 2+ ) is the most abundant biological metal ion aside from iron and is an essential
element in numerous biological systems, acting as a cofactor for a large number of enzymes …

[PDF][PDF] The Toxoplasma vacuolar H+-ATPase regulates intracellular pH and impacts the maturation of essential secretory proteins

AJ Stasic, NM Chasen, EJ Dykes, SA Vella, B Asady… - Cell reports, 2019 - cell.com
Vacuolar-proton ATPases (V-ATPases) are conserved complexes that couple the hydrolysis
of ATP to the pumping of protons across membranes. V-ATPases are known to play diverse …

Effect of standard radiotherapy with cisplatin vs accelerated radiotherapy with panitumumab in locoregionally advanced squamous cell head and neck carcinoma: a …

…, G Liu, A Johnson, G Shenouda, M Chasen… - JAMA …, 2017 - jamanetwork.com
Importance The Canadian Cancer Trials Group study HN.6 is the largest randomized
clinical trial to date comparing the concurrent administration of anti–epidermal growth factor …

Effect of renal denervation on blood pressure in the presence of antihypertensive drugs: 6-month efficacy and safety results from the SPYRAL HTN-ON MED proof-of …

…, M Suppan, T Agdirlioglu, E Noory, C Chasen - The Lancet, 2018 - thelancet.com
Background Previous catheter-based renal denervation studies have reported variable
efficacy results. We aimed to evaluate safety and blood pressure response after renal …

Catheter-based renal denervation in patients with uncontrolled hypertension in the absence of antihypertensive medications (SPYRAL HTN-OFF MED): a randomised …

…, A Brown, M Suppan, T Agdirlioglu, E Noory, C Chasen - The Lancet, 2017 - thelancet.com
Background Previous randomised renal denervation studies did not show consistent efficacy
in reducing blood pressure. The objective of our study was to evaluate the effect of renal …

[HTML][HTML] Health-related quality of life in patients with progressive midgut neuroendocrine tumors treated with 177Lu-dotatate in the phase III NETTER-1 trial

J Strosberg, E Wolin, B Chasen, M Kulke… - Journal of Clinical …, 2018 - ncbi.nlm.nih.gov
Purpose Neuroendocrine tumor (NET) progression is associated with deterioration in quality
of life (QoL). We assessed the impact of 177 Lu-Dotatate treatment on time to deterioration …

Efficacy of catheter-based renal denervation in the absence of antihypertensive medications (SPYRAL HTN-OFF MED Pivotal): a multicentre, randomised, sham …

…, J Campbell, S Carroll, N Chapman, C Chasen… - The Lancet, 2020 - thelancet.com
Background Catheter-based renal denervation has significantly reduced blood pressure in
previous studies. Following a positive pilot trial, the SPYRAL HTN-OFF MED (SPYRAL Pivotal…